You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA Matched Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +4 more
  • (no location specified)
Oct 18, 2022

Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation

Completed
  • Stem Cell Transplantation
    • Princeton, New Jersey
      Local Institution
    Jun 13, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

    Recruiting
    • Severe Aplastic Anemia
    • Atlanta, Georgia
    • +1 more
    Apr 4, 2022

    Viral Infections After HSCT Trial in Washington (VSTs)

    Active, not recruiting
    • Viral Infections After HSCT
    • VSTs
    • Washington, District of Columbia
      Childrens National Medical Center
    Aug 30, 2022

    Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Feb 2, 2022

    Kidney Transplant Rejection Trial in Canada, United States (MDR-101)

    Active, not recruiting
    • Kidney Transplant Rejection
    • MDR-101
    • La Jolla, California
    • +19 more
    Aug 22, 2022

    Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

    Recruiting
    • Myeloid Malignancies
    • GvHD prophylaxis
    • Alessandria, Italy
    • +32 more
    Nov 23, 2022

    Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

    Active, not recruiting
    • Primary Immunodeficiency
    • PID
    • CD3/CD19 neg allogeneic BMT
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of University of Pittsburgh Me
    Oct 6, 2021

    Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)

    Completed
    • Severe Aplastic Anemia
    • Bone Marrow Failure Syndromes
    • Bone marrow transplant
    • +7 more
    • Baltimore, Maryland
    • +1 more
    Feb 10, 2022

    Acute Myeloid Leukemia, Advanced MDS Trial in New York (Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin,

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Advanced Myelodysplastic Syndromes
    • Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Aug 27, 2021

    Hematologic Diseases Trial in Palo Alto (biological, device, drug)

    Recruiting
    • Hematologic Diseases
    • Allogeneic Stem Cell Transplant
    • +2 more
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Mar 25, 2022

    SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

    Not yet recruiting
    • SIOD With CKD Stage 3 Through 5
    • +3 more
    • Cyclophosphamide 1200 mg/Kg
    • +8 more
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Aug 17, 2022

    Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic

    Enrolling by invitation
    • Severe Combined Immunodeficiency (SCID)
    • +8 more
    • CD3/CD19 negative allogeneic hematopoietic stem cells
    • Pittsburgh, Pennsylvania
      Children's Hospital of Pittsburgh of UPMC
    Dec 6, 2021

    Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)

    Completed
    • Multiple Myeloma
    • Amyloidosis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Aug 24, 2021

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • (no location specified)
    Oct 1, 2023

    GVHD Trial (Grafalon, Thymoglobulin)

    Not yet recruiting
    • GVHD
    • (no location specified)
    Oct 9, 2023

    Hematologic Tumors Trial run by the NCI (Stem cell transplantation, Fludarabine, Cyclophosphamide)

    Completed
    Has Results
    • Hematologic Neoplasms
    • Stem cell transplantation
    • +9 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 19, 2021

    Infection Trial in Houston (Multivirus Specific T cells)

    Completed
    Has Results
    • Infection
    • Multivirus Specific T cells
    • Houston, Texas
    • +1 more
    Jul 16, 2021

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +16 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 1, 2022

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    Expanding Scope of Post-transplant HLA-specific Antibody

    Not yet recruiting
    • Kidney Transplant
    • +7 more
    • cf-DNA
    • +2 more
    • Liverpool, Merseyside, United Kingdom
      Liverpool University Hospitals NHS Foundation Trust
    Aug 29, 2023

    Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

    Recruiting
    • Hematologic Malignancy
    • Stem Cell Transplant Complications
    • Beijing protocol
    • Beijing, Beijing, China
      Deparment of Hematology, Peking University People's Hospital
    Jun 19, 2023

    Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)

    Completed
    Has Results
    • Hematologic Malignancies
    • Stem Cell Transplant
    • +5 more
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Oct 30, 2020

    Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

    Recruiting
    • Hematologic Malignancies
    • Haplo HCT <55 years old
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 25, 2023